Causal and Synthetic Associations of Variants in the SERPINA Gene Cluster with Alpha1-antitrypsin Serum Levels

PLoS Genetics

Volumn 9, Issue 8, 2013, Pages

  Thun, Gian Andri ^a,b   Imboden, Medea ^a,b   Ferrarotti, Ilaria ^c   Kumar, Ashish ^a,b,d   Obeidat, Ma'en ^e   Zorzetto, Michele ^c   Haun, Margot ^f   Curjuric, Ivan ^a,b   Couto Alves, Alexessander ^g   Jackson, Victoria E ^h   Albrecht, Eva ⁱ   Ried, Janina S ⁱ   Teumer, Alexander ^j   Lopez, Lorna M ^k   Huffman, Jennifer E ^k   Enroth, Stefan ^l   Bossé, Yohan ^m   Hao, Ke ⁿ   Timens, Wim ^o   Gyllensten, Ulf ^l   Polasek, Ozren ^p   Wilson, James F ^q   Rudan, Igor ^q   Hayward, Caroline ^k   Sandford, Andrew J ^e   Deary, Ian J ^k   Koch, Beate ^j   Reischl, Eva ⁱ   Schulz, Holger ⁱ   Hui, Jennie ^r,s   James, Alan L ^t,u   Rochat, Thierry ^v   Russi, Erich W ^w   Jarvelin, Marjo Riitta ^g,x,y,z   Strachan, David P ^aa   Hall, Ian P ^ab   Tobin, Martin D ^h   Dahl, Morten ^ac   Fallgaard Nielsen, Sune ^ad   Nordestgaard, Børge G ^ad   Kronenberg, Florian ^f   Luisetti, Maurizio ^c   Probst Hensch, Nicole M ^a,b   more..

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF LEICESTER   (United Kingdom)

ⁱ INSTITUTE OF EPIDEMIOLOGY   (Germany)

^j UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l UPPSALA UNIVERSITY   (Sweden)

^m LAVAL UNIVERSITY   (Canada)

ⁿ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^p UNIVERSITY OF SPLIT   (Croatia)

^q UNIVERSITY OF EDINBURGH   (United Kingdom)

^r UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^s Busselton Population Medical Research Institute   (Australia)

^t West Australian Sleep Disorders Research Institute   (Australia)

^u UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^v GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^w UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^x UNIVERSITY OF OULU   (Finland)

^y OULU UNIVERSITY HOSPITAL   (Finland)

^z NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^aa ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^ab QUEEN S MEDICAL CENTRE   (United Kingdom)

^ac Rigshospitalet   (Denmark)

^ad GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EXON; GENE CLUSTER; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENE LOCUS; GENE REPLICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; PROMOTER REGION; PROTEIN BLOOD LEVEL; SERPINA1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ALPHA 1-ANTITRYPSIN; DENMARK; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LUNG; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84884642095     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003585     Document Type: Article

References (68)

1. Brantly ML, Wittes JT, Vogelmeier CF, Hubbard RC, Fells GA, et al. (1991) Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes. Chest 100: 703-708.
2. Lomas DA, Evans DL, Finch JT, Carrell RW, (1992) The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357: 605-607.
3. Luisetti M, Seersholm N, (2004) Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax 59: 164-169.
4. Lieberman J, Winter B, Sastre A, (1986) Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 89: 370-373.
5. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 168: 818-900.
6. Hersh CP, Dahl M, Ly NP, Berkey CS, Nordestgaard BG, et al. (2004) Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax 59: 843-849.
7. Dahl M, Hersh CP, Ly NP, Berkey CS, Silverman EK, et al. (2005) The protease inhibitor PI*S allele and COPD: a meta-analysis. Eur Respir J 26: 67-76.
8. Sorheim IC, Bakke P, Gulsvik A, Pillai SG, Johannessen A, et al. (2010) alpha-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest 138: 1125-1132.
9. Thun GA, Ferrarotti I, Imboden M, Rochat T, Gerbase M, et al. (2012) SERPINA1 PiZ and PiS Heterozygotes and Lung Function Decline in the SAPALDIA Cohort. PLoS One 7: e42728.
10. Wilk JB, Shrine NR, Loehr LR, Zhao JH, Manichaikul A, et al. (2012) Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 186: 622-632.
11. Artigas MS, Loth DW, Wain LV, Gharib SA, Obeidat M, et al. (2011) Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 43: 1082-1090.
12. Imboden M, Bouzigon E, Curjuric I, Ramasamy A, Kumar A, et al. (2012) Genome-wide association study of lung function decline in adults with and without asthma. J Allergy Clin Immunol 129: 1218-1228.
13. Kong X, Cho MH, Anderson W, Coxson HO, Muller N, et al. (2011) Genome-wide Association Study Identifies BICD1 as a Susceptibility Gene for Emphysema. Am J Respir Crit Care Med 183: 43-49.
14. Obeidat M, Wain LV, Shrine N, Kalsheker N, Artigas MS, et al. (2011) A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample. PLoS One 6: e19382.
15. Law RH, Zhang Q, McGowan S, Buckle AM, Silverman GA, et al. (2006) An overview of the serpin superfamily. Genome Biol 7: 216.
16. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB, (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8: e1000294.
17. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, et al. (2010) A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363: 1211-1221.
18. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
19. A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
20. Ferrarotti I, Thun GA, Zorzetto M, Ottaviani S, Imboden M, et al. (2012) Serum levels and genotype distribution of alpha1-antitrypsin in the general population. Thorax 67: 669-674.
21. Zorzetto M, Russi E, Senn O, Imboden M, Ferrarotti I, et al. (2008) SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations. Clin Chem 54: 1331-1338.
22. Miyake K, Suzuki H, Oka H, Oda T, Harada S, (1979) Distribution of alpha 1-antitrypsin phenotypes in Japanese: description of Pi M subtypes by isoelectric focusing. Jinrui Idengaku Zasshi 24: 55-62.
23. Nukiwa T, Takahashi H, Brantly M, Courtney M, Crystal RG, (1987) alpha 1-Antitrypsin nullGranite Falls, a nonexpressing alpha 1-antitrypsin gene associated with a frameshift to stop mutation in a coding exon. J Biol Chem 262: 11999-12004.
24. Graham A, Kalsheker NA, Newton CR, Bamforth FJ, Powell SJ, et al. (1989) Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256----Val); PiMmalton (Phe51----deletion) and PiI (Arg39----Cys). Hum Genet 84: 55-58.
25. Holmes MD, Brantly ML, Crystal RG, (1990) Molecular analysis of the heterogeneity among the P-family of alpha-1-antitrypsin alleles. Am Rev Respir Dis 142: 1185-1192.
26. Okayama H, Brantly M, Holmes M, Crystal RG, (1991) Characterization of the molecular basis of the alpha 1-antitrypsin F allele. Am J Hum Genet 48: 1154-1158.
27. Faber JP, Poller W, Weidinger S, Kirchgesser M, Schwaab R, et al. (1994) Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele. Am J Hum Genet 55: 1113-1121.
28. Poller W, Merklein F, Schneider-Rasp S, Haack A, Fechner H, et al. (1999) Molecular characterisation of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile). Eur J Hum Genet 7: 321-331.
29. Fra AM, Gooptu B, Ferrarotti I, Miranda E, Scabini R, et al. (2012) Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization. PLoS One 7: e38405.
30. Gibson G, (2011) Rare and common variants: twenty arguments. Nat Rev Genet 13: 135-145.
31. Sanna S, Li B, Mulas A, Sidore C, Kang HM, et al. (2011) Fine mapping of five Loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability. PLoS Genet 7: e1002198.
32. Oosterveer DM, Versmissen J, Defesche JC, Sivapalaratnam S, Yazdanpanah M, et al. (2013) Low-density lipoprotein receptor mutations generate synthetic genome-wide associations. Eur J Hum Genet 21: 563-566.
33. Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, et al. (2010) Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet 42: 1049-1051.
34. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, et al. (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43: 1066-1073.
35. Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, et al. (2010) Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 42: 684-687.
36. Coassin S, Schweiger M, Kloss-Brandstatter A, Lamina C, Haun M, et al. (2010) Investigation and functional characterization of rare genetic variants in the adipose triglyceride lipase in a large healthy working population. PLoS Genet 6: e1001239.
37. Kronenberg F, Utermann G, (2013) Lipoprotein(a): resurrected by genetics. J Intern Med 273: 6-30.
38. Lin JP, Schwaiger JP, Cupples LA, O'Donnell CJ, Zheng G, et al. (2009) Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels-the Framingham Heart Study. Atherosclerosis 206: 228-233.
39. Heid IM, Wagner SA, Gohlke H, Iglseder B, Mueller JC, et al. (2006) Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55: 375-384.
40. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, et al. (2009) Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41: 47-55.
41. Chappell S, Daly L, Morgan K, Guetta Baranes T, Roca J, et al. (2006) Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat 27: 103-109.
42. Silverman EK, Province MA, Rao DC, Pierce JA, Campbell EJ, (1990) A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency. Quantitative phenotypes. Am Rev Respir Dis 142: 1015-1021.
43. Senn O, Russi EW, Schindler C, Imboden M, von Eckardstein A, et al. (2008) Circulating alpha1-antitrypsin in the general population: determinants and association with lung function. Respir Res 9: 35.
44. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, et al. (2008) Genetics of gene expression and its effect on disease. Nature 452: 423-428.
45. Hao K, Bosse Y, Nickle DC, Pare PD, Postma DS, et al. (2012) Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet 8: e1003029.
46. Inouye M, Ripatti S, Kettunen J, Lyytikainen LP, Oksala N, et al. (2012) Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet 8: e1002907.
47. Lappalainen T, Montgomery SB, Nica AC, Dermitzakis ET, (2011) Epistatic selection between coding and regulatory variation in human evolution and disease. Am J Hum Genet 89: 459-463.
48. Qiu W, Baccarelli A, Carey VJ, Boutaoui N, Bacherman H, et al. (2012) Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 185: 373-381.
49. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, et al. (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467: 832-838.
50. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, et al. (2011) Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 43: 1193-1201.
51. Rollini P, Fournier RE, (1999) The HNF-4/HNF-1alpha transactivation cascade regulates gene activity and chromatin structure of the human serine protease inhibitor gene cluster at 14q32.1. Proc Natl Acad Sci USA 96: 10308-10313.
52. Martin BW, Ackermann-Liebrich U, Leuenberger P, Kunzli N, Stutz EZ, et al. (1997) SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed 42: 67-84.
53. Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, Schindler C, Felber Dietrich D, et al. (2005) Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991-2003: methods and characterization of participants. Soz Praventivmed 50: 245-263.
54. Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG, (2002) Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Ann Intern Med 136: 270-279.
55. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, et al. (2001) Susceptibility genes for rapid decline of lung function in the Lung Health Study. American Journal of Respiratory and Critical Care Medicine 163: 469-473.
56. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR, (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34: 816-834.
57. Carter KW, McCaskie PA, Palmer LJ, (2006) JLIN: a java based linkage disequilibrium plotter. BMC Bioinformatics 7: 60.
58. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
59. Hemminger BM, Saelim B, Sullivan PF, (2006) TAMAL: an integrated approach to choosing SNPs for genetic studies of human complex traits. Bioinformatics 22: 626-627.
60. Chappell S, Hadzic N, Stockley R, Guetta-Baranes T, Morgan K, et al. (2008) A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease. Hepatology 47: 127-132.
61. Gorrini M, Ferrarotti I, Lupi A, Bosoni T, Mazzola P, et al. (2006) Validation of a rapid, simple method to measure alpha1-antitrypsin in human dried blood spots. Clin Chem 52: 899-901.
62. Aulchenko YS, Struchalin MV, van Duijn CM, (2010) ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics 11: 134.
63. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
64. Heath SC, Gut IG, Brennan P, McKay JD, Bencko V, et al. (2008) Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet 16: 1413-1429.
65. Li J, Ji L, (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 95: 221-227.
66. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337.
67. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938-2939.
68. Kumar P, Henikoff S, Ng PC, (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4: 1073-1081.